AbbVie Inc (NYSE: ABBV) saw its stock fall nearly 13% after reporting disappointing mid-stage trial results for emraclidine, ...

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday. *No charge for 4 weeks then ...

A recent outbreak of E coli linked to McDonald's restaurants has raised concerns among public health officials, consumers, and the food industry. Reports of illnesses across multiple locations have ...

"It is our responsibility and privilege to help advance research and understanding of MDD and schizophrenia so we can continue to deliver transformational therapies that address the greatest unmet ...

Symptoms of schizophrenia, a serious mental disorder that can include hallucinations and delusions, vary greatly from person to person. One common group of schizophrenia symptoms that doesn’t ...

Schizophrenia is a chronic and complicated psychiatric and psychological illness. It is characterized by a set of symptoms that include hallucinations, delusions, speech or behavioral disorders, ...

Of the Rs 12,500 crore IPO, Rs 10,000 crore is the shares that HDFC Bank intends to sell. The board of directors have approved the IPO HDFC Bank, the country's largest private sector lender, is ...

Anavex Life Sciences has reported encouraging initial results from the Phase 2 study of ANAVEX3-71, showing dose-dependent effects on key EEG biomarkers in schizophrenia patients. These outcomes ...